Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response.

Harling-McNabb L, Deliyannis G, Jackson DC, Gerondakis S, Grigoriadis G, Brown LE.

Int Immunol. 1999 Sep;11(9):1431-9.

PMID:
10464164
2.

CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.

Lee YT, Ko EJ, Lee Y, Lee YN, Bian Z, Liu Y, Kang SM.

J Virol. 2016 Jul 11;90(15):6746-6758. doi: 10.1128/JVI.00605-16. Print 2016 Aug 1.

3.

Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses.

Bot A, Holz A, Christen U, Wolfe T, Temann A, Flavell R, von Herrath M.

Virology. 2000 Mar 30;269(1):66-77.

4.
5.

Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.

Kamlangdee A, Kingstad-Bakke B, Osorio JE.

J Virol. 2016 Jul 11;90(15):6771-6783. doi: 10.1128/JVI.00730-16. Print 2016 Aug 1.

7.
9.

Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs.

Dutta A, Huang CT, Lin CY, Chen TC, Lin YC, Chang CS, He YC.

Sci Rep. 2016 Sep 6;6:32973. doi: 10.1038/srep32973.

10.

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.

Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price DA, Wilschut J, de Haan A.

PLoS One. 2012;7(1):e30898. doi: 10.1371/journal.pone.0030898. Epub 2012 Jan 27.

11.

Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.

Lee YN, Lee YT, Kim MC, Hwang HS, Lee JS, Kim KH, Kang SM.

Immunology. 2014 Oct;143(2):300-9. doi: 10.1111/imm.12310.

12.

Mouse Models Reveal Role of T-Cytotoxic and T-Reg Cells in Immune Response to Influenza: Implications for Vaccine Design.

Sell S, McKinstry KK, Strutt TM.

Viruses. 2019 Jan 11;11(1). pii: E52. doi: 10.3390/v11010052. Review.

13.

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.

Price GE, Gaszewska-Mastarlarz A, Moskophidis D.

J Virol. 2000 May;74(9):3996-4003.

14.
15.

Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.

Tao P, Luo M, Pan R, Ling D, Zhou S, Tien P, Pan Z.

Antiviral Res. 2009 Mar;81(3):253-60. doi: 10.1016/j.antiviral.2008.12.009. Epub 2009 Jan 9.

PMID:
19135483
16.
17.

Cytotoxic T cells are the predominant players providing cross-protective immunity induced by {gamma}-irradiated influenza A viruses.

Furuya Y, Chan J, Regner M, Lobigs M, Koskinen A, Kok T, Manavis J, Li P, Müllbacher A, Alsharifi M.

J Virol. 2010 May;84(9):4212-21. doi: 10.1128/JVI.02508-09. Epub 2010 Feb 17.

18.

Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A.

J Exp Med. 2009 Jan 16;206(1):79-87. doi: 10.1084/jem.20081667. Epub 2009 Jan 12.

19.

Environmental and antigen receptor-derived signals support sustained surveillance of the lungs by pathogen-specific cytotoxic T lymphocytes.

Lee YT, Suarez-Ramirez JE, Wu T, Redman JM, Bouchard K, Hadley GA, Cauley LS.

J Virol. 2011 May;85(9):4085-94. doi: 10.1128/JVI.02493-10. Epub 2011 Feb 23.

20.

Polyanhydride nanovaccine against swine influenza virus in pigs.

Dhakal S, Goodman J, Bondra K, Lakshmanappa YS, Hiremath J, Shyu DL, Ouyang K, Kang KI, Krakowka S, Wannemuehler MJ, Won Lee C, Narasimhan B, Renukaradhya GJ.

Vaccine. 2017 Feb 22;35(8):1124-1131. doi: 10.1016/j.vaccine.2017.01.019. Epub 2017 Jan 20.

PMID:
28117173

Supplemental Content

Support Center